Aprea Therapeutics Inc (APRE) is around the top of the Biotechnology industry according to InvestorsObserver. APRE received an overall rating of 55, which means that it scores higher than 55 percent of all stocks. Aprea Therapeutics Inc also achieved a score of 75 in the Biotechnology industry, putting it above 75 percent of Biotechnology stocks. Biotechnology is ranked 73 out of the 148 industries.
APRE has an Overall Score of 55. Find out what this means to you and get the rest of the rankings on APRE!